Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study
Andrea Arfè(University of Milano-Bicocca), Giovanni Corrao(University of Milano-Bicocca), Alexandre Pariente(Université de Bordeaux), Miriam Sturkenboom, Lorenza Scotti(University of Milano-Bicocca), S Lucchi(Azienda Socio Sanitaria Territoriale di Cremona), R Schade(Charité - Universitätsmedizin Berlin), Marco Villa(Azienda Socio Sanitaria Territoriale di Cremona), Tania Schink(Leibniz Institute for Prevention Research and Epidemiology - BIPS), Edeltraut Garbe(Leibniz Institute for Prevention Research and Epidemiology - BIPS), Antonella Zambon(University of Milano-Bicocca), Vera E. Valkhoff, Bianca Kollhorst(Leibniz Institute for Prevention Research and Epidemiology - BIPS), Silvana Romio, Ron M. C. Herings(Pharmo Institute), Martijn J. Schuemie, Cristina Varas‐Lorenzo, Huub Straatman(Pharmo Institute), Federica Nicotra(University of Milano-Bicocca), Frantz Thiessard(Université de Bordeaux)
Cited by 284
Related Papers
Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation
|New England Journal of Medicine|2007|714
Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data
|BMJ|2017|525
Systematic Review: Agranulocytosis Induced by Nonchemotherapy Drugs
|Annals of Internal Medicine|2007|476